Achieving hemostasis with the JADA system after induced abortion at 12 weeks: A case report

IF 2.8 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Contraception Pub Date : 2025-02-25 DOI:10.1016/j.contraception.2025.110855

Serena Ly , Sheeva Yazdani , Nicole Economou

引用次数: 0

Abstract

The JADA system is safe and effective for control of abnormal postpartum bleeding and hemorrhage at gestational ages (GA) greater than 34 weeks. This report describes successful use of the JADA to control significant uterine atony and hemorrhage in a patient undergoing procedural abortion at 12 weeks 3 days gestation.

查看原文本刊更多论文

人工流产12周后Jada系统止血1例。

JADA系统对产后异常出血及胎龄大于34周出血的控制安全有效。本报告描述了成功地使用JADA控制显著子宫张力和出血的病人进行手术流产在妊娠12周3天。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Contraception 医学-妇产科学

CiteScore

4.70

自引率

17.20%

发文量

211

审稿时长

69 days

期刊介绍： Contraception has an open access mirror journal Contraception: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.